标题
The Inflammatory Chemokine CCL5 and Cancer Progression
作者
关键词
-
出版物
MEDIATORS OF INFLAMMATION
Volume 2014, Issue -, Pages 1-12
出版商
Hindawi Limited
发表日期
2014-01-03
DOI
10.1155/2014/292376
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Potentin vitroandin vivoactivity of sorafenib in multiple myeloma: induction of cell death, CD138-downregulation and inhibition of migration through actin depolymerization
- (2013) Josefina Udi et al. BRITISH JOURNAL OF HAEMATOLOGY
- CCL5 as a potential immunotherapeutic target in triple-negative breast cancer
- (2013) Dandan Lv et al. Cellular & Molecular Immunology
- Tumour-associated macrophages and cancer
- (2013) Jenny Cook et al. CURRENT OPINION IN PHARMACOLOGY
- CCR1/CCL5 interaction promotes invasion of taxane-resistant PC3 prostate cancer cells by increasing secretion of MMPs 2/9 and by activating ERK and Rac signaling
- (2013) Taku Kato et al. CYTOKINE
- Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
- (2013) Rakesh K. Jain JOURNAL OF CLINICAL ONCOLOGY
- ‘Cancer associated fibroblasts’ – more than meets the eye
- (2013) Shalom Madar et al. TRENDS IN MOLECULAR MEDICINE
- Mesenchymal stem cell-derived CCL-9 and CCL-5 promote mammary tumor cell invasion and the activation of matrix metalloproteinases
- (2013) Muthulekha Swamydas et al. Cell Adhesion & Migration
- One cell, multiple roles: contribution of mesenchymal stem cells to tumor development in tumor microenvironment
- (2013) Xue Yang et al. Cell and Bioscience
- The potential role of anibamine, a natural product CCR5 antagonist, and its analogues as leads toward development of anti-ovarian cancer agents
- (2012) Yan Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease
- (2012) D. J. Dairaghi et al. BLOOD
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Tumor-Derived Chemokine CCL5 Enhances TGF- -Mediated Killing of CD8+ T Cells in Colon Cancer by T-Regulatory Cells
- (2012) L.-Y. Chang et al. CANCER RESEARCH
- CCR5 Antagonist Blocks Metastasis of Basal Breast Cancer Cells
- (2012) M. Velasco-Velazquez et al. CANCER RESEARCH
- Chemokine C-C motif receptor 5 and C-C motif ligand 5 promote cancer cell migration under hypoxia
- (2012) Sensen Lin et al. CANCER SCIENCE
- A novel role of hematopoietic CCL5 in promoting triple-negative mammary tumor progression by regulating generation of myeloid-derived suppressor cells
- (2012) Yan Zhang et al. CELL RESEARCH
- Structure activity relationship studies of natural product chemokine receptor CCR5 antagonist anibamine toward the development of novel anti prostate cancer agents
- (2012) Feng Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- CCR5 inhibitors: emergence, success, and challenges
- (2012) Kenji Maeda et al. EXPERT OPINION ON EMERGING DRUGS
- The Chemokine Superfamily Revisited
- (2012) Albert Zlotnik et al. IMMUNITY
- Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity
- (2012) Cinzia Borghese et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Cancer-Related Inflammation
- (2012) Juliana Candido et al. JOURNAL OF CLINICAL IMMUNOLOGY
- IL-15 Can Signal via IL-15R , JNK, and NF- B To Drive RANTES Production by Myeloid Cells
- (2012) M. J. Chenoweth et al. JOURNAL OF IMMUNOLOGY
- Tumor-Infiltrating Monocytic Myeloid-Derived Suppressor Cells Mediate CCR5-Dependent Recruitment of Regulatory T Cells Favoring Tumor Growth
- (2012) E. Schlecker et al. JOURNAL OF IMMUNOLOGY
- Can we change the disease biology of multiple myeloma?
- (2012) Ivan Borrello LEUKEMIA RESEARCH
- STAT3-RANTES Autocrine Signaling Is Essential for Tamoxifen Resistance in Human Breast Cancer Cells
- (2012) E. H. Yi et al. MOLECULAR CANCER RESEARCH
- CCL5 and CCR5 Interaction Promotes Cell Motility in Human Osteosarcoma
- (2012) Shih-Wei Wang et al. PLoS One
- Deficiency of C-C Chemokine Receptor 5 Suppresses Tumor Development via Inactivation of NF-κB and Upregulation of IL-1Ra in Melanoma Model
- (2012) Ju Kyoung Song et al. PLoS One
- Autocrine CCL5 Signaling Promotes Invasion and Migration of CD133+Ovarian Cancer Stem-Like Cells via NF-κB-Mediated MMP-9 Upregulation
- (2012) Haixia Long et al. STEM CELLS
- MicroRNAs Reprogram Normal Fibroblasts into Cancer-Associated Fibroblasts in Ovarian Cancer
- (2012) A. K. Mitra et al. Cancer Discovery
- Zoledronic acid blocks the interaction between mesenchymal stem cells and breast cancer cells: implications for adjuvant therapy of breast cancer
- (2011) M. Gallo et al. ANNALS OF ONCOLOGY
- PI3K inhibitor, GS-1101 (CAL-101), attenuates pathway signaling, induces apoptosis, and overcomes signals from the microenvironment in cellular models of Hodgkin lymphoma
- (2011) S. A. Meadows et al. BLOOD
- Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis
- (2011) Zhiyong Mi et al. CARCINOGENESIS
- Chemokines in health and disease
- (2011) Dayanidhi Raman et al. EXPERIMENTAL CELL RESEARCH
- CCR1 as a target for multiple myeloma
- (2011) Sonia Vallet et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Role of RANTES and its receptor in gastric cancer metastasis
- (2011) Zhixin Cao et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- The chemokine system and cancer
- (2011) Frances R Balkwill JOURNAL OF PATHOLOGY
- A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function
- (2011) S Vallet et al. LEUKEMIA
- The role of CD40/CD40L and interferon regulatory factor 4 in Hodgkin lymphoma microenvironment
- (2011) Donatella Aldinucci et al. LEUKEMIA & LYMPHOMA
- CCL5 Neutralization Restricts Cancer Growth and Potentiates the Targeting of PDGFRβ in Colorectal Carcinoma
- (2011) Béatrice Cambien et al. PLoS One
- Anibamine, a natural product CCR5 antagonist, as a novel lead for the development of anti-prostate cancer agents
- (2010) Xueping Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Chemokine receptors as therapeutic tools in Hodgkin lymphoma: CCR4 and beyond
- (2010) D. Aldinucci et al. BLOOD
- IRF4 silencing inhibits Hodgkin lymphoma cell proliferation, survival and CCL5 secretion
- (2010) Donatella Aldinucci et al. BRITISH JOURNAL OF HAEMATOLOGY
- Molecular Pathways Linking Inflammation and Cancer
- (2010) A. Mantovani CURRENT MOLECULAR MEDICINE
- Chemokines in cancer related inflammation
- (2010) Paola Allavena et al. EXPERIMENTAL CELL RESEARCH
- The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients
- (2010) Yanran Cao et al. EXPERIMENTAL HEMATOLOGY
- The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape
- (2010) Donatella Aldinucci et al. JOURNAL OF PATHOLOGY
- LYR71, a derivative of trimeric resveratrol, inhibits tumorigenesis by blocking STAT3-mediated matrix metalloproteinase 9 expression
- (2009) Ja Eun Kim et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Increased expression of macrophage inflammatory protein-1α on trephine biopsies correlates with extensive bone disease, increased angiogenesis and advanced stage in newly diagnosed patients with multiple myeloma
- (2009) M Roussou et al. LEUKEMIA
- Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24− phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression
- (2009) Sun ONCOLOGY REPORTS
- The Prostate Specific Membrane Antigen Regulates the Expression of IL-6 and CCL5 in Prostate Tumour Cells by Activating the MAPK Pathways1
- (2009) Marco Colombatti et al. PLoS One
- Expression of the Epstein-Barr Virus-Encoded Epstein-Barr Virus Nuclear Antigen 1 in Hodgkin's Lymphoma Cells Mediates Up-Regulation of CCL20 and the Migration of Regulatory T Cells
- (2008) Karl R.N. Baumforth et al. AMERICAN JOURNAL OF PATHOLOGY
- CCL5 increases lung cancer migration via PI3K, Akt and NF-κB pathways
- (2008) Chun-Yin Huang et al. BIOCHEMICAL PHARMACOLOGY
- Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22
- (2008) Marijke Niens et al. BRITISH JOURNAL OF HAEMATOLOGY
- The inflammatory chemokines CCL2 and CCL5 in breast cancer
- (2008) Gali Soria et al. CANCER LETTERS
- Gastric cancer cells exploit CD4+ cell-derived CCL5 for their growth and prevention of CD8+ cell-involved tumor elimination
- (2008) Hidekazu Sugasawa et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic significance of expression of CCL5/RANTES receptors in patients with gastric cancer
- (2008) Hidekazu Sugasawa et al. JOURNAL OF SURGICAL ONCOLOGY
- MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death
- (2008) R Schickel et al. ONCOGENE
- Expression of CCR5 receptors on Reed–Sternberg cells and Hodgkin lymphoma cell lines: Involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions
- (2007) Donatella Aldinucci et al. INTERNATIONAL JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More